The Managed Markets Fellowship, offered by University of the Sciences through a generous grant from Genentech (a member of the Roche Group), is designed to provide opportunities for graduating USciences seniors and recent alumni to develop core knowledge in managed care markets through coursework, mentoring, and real-world experiences. Upon completion of this two-year fellowship, participants will be well-prepared to assume key roles in the industry and have confidence in their critical thinking and business skills. This opportunity is salaried with benefits and although post-fellowship employment is not guaranteed, fellows will be in a strong position for leadership opportunities within the Genentech organization. The Managed Markets Fellowship is offered and administered through Mayes College of Healthcare Business & Policy.
The Managed Markets Fellowship is a two-year, salaried program designed to give its members research as well as on hands-on, real-world experience in a wide range of managed care areas.
Year one will take place at USciences and consist of:
Year two will take place at Genentech headquarters in South San Francisco, California. This portion of the fellowship will consist of rotations within the Managed Care and Customer Operations division in areas such as Strategic Pricing and Contract Management, Access Solutions, Channel Distribution Strategies, and Managed Care Marketing.
All candidates interested in the fellowship must satisfy the following requirements:
No employee or contractor of Genentech and University of the Sciences may apply for the fellowship during the time of his/her employment or contract, nor may an award be offered to any person who has been employed by or under contract of either institution in the previous year, without prior approval.
Click here for application and instructions (Word doc).
Genentech is motivated by a desire to make a difference in the lives of patients with serious and life-threatening diseases. Considered a pioneer in the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline, and a long term plan for growth.
For additional information on the Managed Markets Fellowship contact Mary Kate McGinty, Executive Director of External Affairs for Mayes College via email at email@example.com or 215.596.8719.